Body composition and neuromotor development in the year after NICU discharge in premature infants.

BACKGROUND: Hypothesis: neuromotor development correlates to body composition over the first year of life in prematurely born infants and can be influenced by enhancing motor activity.
METHODS: Forty-six female and 53 male infants [27 ± 1.8 (sd) weeks] randomized to comparison or exercise group (caregiver provided 15-20 min daily of developmentally appropriate motor activities) completed the year-long study. Body composition [lean body and fat mass (LBM, FM)], growth/inflammation predictive biomarkers, and Alberta Infant Motor Scale (AIMS) were assessed.
RESULTS: AIMS at 1 year correlated with LBM (r = 0.32, p < 0.001) in the whole cohort. However, there was no effect of the intervention. LBM increased by ~3685 g (p < 0.001)); insulin-like growth factor-1 (IGF-1) was correlated with LBM (r = 0.36, p = 0.002). IL-1RA (an inflammatory biomarker) decreased (-75%, p < 0.0125). LBM and bone mineral density were significantly lower and IGF-1 higher in the females at 1 year.
CONCLUSIONS: We found an association between neuromotor development and LBM suggesting that motor activity may influence LBM. Our particular intervention was ineffective. Whether activities provided largely by caregivers to enhance motor activity in prematurely born infants can affect the interrelated (1) balance of growth and inflammation mediators, (2) neuromotor development, (3) sexual dimorphism, and/or (4) body composition early in life remains unknown.

RCT Entities:   Population Interventions Outcomes

INTRODUCTION

Project BEGIN (Body Composition, Exercise, and Growth in Preterm Newborns) was designed to 1) fill gaps in our understanding of the relationship between body composition, neuromotor development, and sex in infants born prematurely during the first year of life and 2) determine whether these relationships could be altered by a parent/caregiver administered program to increase motor and physical activity in these infants. We hypothesized that in prematurely born infants during the first year of life following discharge from the neonatal intensive care unit (NICU): 1) neuromotor development would be correlated to body composition; 2) these interactions would be influenced by sex; and 3) a caregiver administered intervention to increase motor activity would lead to more rapid increases in the development of fat free mass and neuromotor responsiveness. Although there is some evidence that physical activity interventions early in life can benefit body composition (1), the effect of the energy-expenditure side of energy balance (namely, motor or physical activity) on neuromotor development remains inadequately understood.

Extreme, moderate, and late premature birth are associated with adverse effects across the lifespan, in particular impairment in neuromotor function (2). Remarkable progress has been made over the past several decades in improving the NICU care of prematurely born infants. Far less is known about how to optimize neuromotor development in these infants following NICU discharge, and the transition from NICU to home can be profoundly challenging for the caregivers (3). Both body composition and neuromotor performance rapidly evolve (and often in an abnormal manner) early in the lives of prematurely born children. Consequently, physical rehabilitative interventions administered by caregivers following NICU discharge are compelling, minimally invasive, and potentially modifiable approaches for mitigating long term health consequences of prematurity (4).

Neuromotor performance and body composition components [i.e., lean body mass (LBM), bone mineral content (BMC) and density (BMD), and fat mass (FM)] are linked across the lifespan both in young children (5) and adults (6), and in studies performed in animal models, increasing motor activity in the immediate postnatal period led to increased muscle mass later in life (7). Circulating osteocalcin is an early indicator of bone mass development in preterm infants (8). The development of LBM is mediated by growth factors like insulin-like growth factor-1 (IGF-1), and inhibited by inflammatory mediators (9). The clinical relevance of IGF-1 in particular is highlighted by its therapeutic use in preterm infants to attenuate retinopathy of prematurity and bronchopulmonary dysplasia (10).

Consequently, we measured IGF-1 and osteocalcin and, as indicators of inflammation, interleukin-6 (IL-6) (11) and interleukin-1 receptor antagonist (IL-1RA). IL-1RA is elevated in inflammatory states and there is mounting preclinical data indicating that therapeutic IL-1 antagonism may reduce inflammation-induced injury in prematurity (12). Equally important are data highlighting the need to address sexual dimorphism. For example, sex-associated differences in motor performance can be observed in children as young as 3 years-old (13) and in neuromotor function in adolescents exposed prenatally or in early childhood to environmental toxins (14).

METHODS

Study Overview.

The overall study strategy is shown in Figure 1. Prematurely born infants were randomly assigned to either: 1) a parent/caregiver implemented assisted exercise and enhanced social interaction program (E), or 2) an enhanced social interaction alone comparison group (C). At NICU discharge and one year following discharge, enrolled infants were studied for body composition [by dual x-ray absorptiometry (DXA)], circulating mediators of growth and inflammation, and neurodevelopment by the progression of standardized tests [Test of Infant Motor Performance (TIMP), which was specifically designed to test neuromotor performance in the first months of postnatal life (15)]. The TIMP was performed at hospital discharge and again at 3 months corrected age, and the Alberta Infant Motor Scale (AIMS)— an observational assessment scale constructed to measure gross motor maturation in infants from birth through independent walking (16) was performed at 3 months and 1 year corrected age.

Figure 1.

Study overview. TIMP is Test of Infant Motor Performance; AIMS is Alberta Infant Motor Scale (see text).

Both the assisted-exercise and comparison groups received structured social interaction approaches developed by Spittle and colleagues (17). Social interaction activities were designed to enhance the engagement of caregivers with their infants through singing, speaking, and storytelling, activities which have been shown to improve postnatal development in prematurely born newborns (4). We purposefully chose to provide the social interaction instruction to the comparison group, rather than randomize to a more traditional “routine care” control group because we reached the conclusion that it would be ethically appropriate to offer potentially beneficial programs to both groups. This study was approved by the UCI Institutional Review Board.

Target Population.

The target population for this study was relatively healthy developing preterm infants nearing discharge from the NICU and their primary care givers (most likely a parent). Infants were enrolled from NICUs in our region, predominantly, UCI, Children’s Hospital of Orange County, and Miller Children’s Hospital. These institutions are part of the regional Clinical Trials Ecosystem, a collaboration sponsored by the UCI Institute for Clinical and Translational Science (ICTS). The study population consisted of all preterm infant-caregiver dyads who meet the inclusion criteria (see Table 1). We also relied on the attending neonatologist’s general impression of whether the infant-caregiver dyad would be likely to complete the study if enrolled.

Table 1.

Project BEGIN Inclusion and Exclusion Criteria

Inclusion criteria:

• Infant is a healthy, growing NICU inpatient and, in the view of the attending neonatologist, unlikely to develop serious complications that would limit study participation.

• Caregiver ≥18 years of age

• Infant gestational age at birth <29weeks

• Infant gestational age at time of study recruitment >34 weeks, on full feeds and nearing discharge

Exclusion criteria:

• Significant lung disease of prematurity requiring supplemental oxygen or corticosteroids at discharge

• Significant intraventricular hemorrhage, grade III –IV

• Necrotizing enterocolitis

• Tracheostomy

• Bone diseases (e.g., osteogenesis imperfecta, hip or knee joint anomalies, arthrogryposis, fractures)

• Skin disorders (e.g., erythematus bullosis)

• Symptomatic congenital heart disease

• Any other conditions or congenital anomalies likely to severely impact the ability of the premature baby and caregiver to participate in a demanding study

Instruction for Caregivers.

Caregivers were taught to perform guided infant exercises by specially trained occupational and physical therapists and shown how to differentiate between appropriate and unsafe handling of infants during the exercises. Training occurred predominantly in the 2 weeks prior to discharge. The families were visited in the home 2 weeks post discharge and the training personnel determined the necessary number of sessions for an individual caregiver/infant dyad based on the trainer’s assessment of how well the caregiver understood and implemented the exercises and how the infants responded. Each parent/caregiver received about 40 min of instruction. No formal assessment of parent/caregiver skill was undertaken. Additional training of the parent/caregiver occurred at the participants’ home at 3, 6 and nine months. As the infants grew and motorically progressed, the intervention protocol was adapted to include exercises neurodevelopmentally appropriate for the infants’ abilities.

Caregivers were asked to conduct the exercises for at least 15–20 minutes every day for one year. The exercise activities in the intervention group were based in part on the principles of Neurodevelopmental Treatment (NDT) (18). NDT- based interventions have been successful in improving gross motor performance in a group of high-risk preterm infants in the NICU (19) and in group of 4- to 12-month-old infants receiving therapy for posture and movement dysfunction (20). We modified the NDT-based activities every two months to address anticipated changes in motor performance over the first year of life. At each home visit the exercises were observed by a physical or occupational therapist and parents were provided direction and training in the new exercises to use for the following 3-month period. In addition, caregivers were provided with a printed, updated list of exercises which many placed in a prominent place (like a refrigerator) to remind them of the daily regimen. Study staff contacted each family 2–3 times per month to touch base and field questions and concerns.

Body Composition.

Standardized measures of length and weight were made at discharge and at one year of age. The change in LBM from discharge to one year was the primary outcome. LBM was measured using DXA in thee ICTS core facility. DXA has been increasingly used for these assessments in children, and in infants and preterm infants(21). DXA scans were done in unanesthetized participants using a whole body fan-beam scanner (Hologic QDR Discovery-A Hologic Inc., Bedford MA). Large scale studies of DXA repeatability in infants are challenging, however, Shepherd and coworkers (22) reported 18 repeated studies from 9 full term infants and found relatively low coefficients of variation in LBM (2.2%) and fat mass (8.4%). To optimize DXA comparability, the studies were scheduled to coincide with each infant’s pattern of napping, and all scans were performed while the infants slept. In addition, all participants were scanned in the same research-dedicated scanner guided by the same single technician (who had substantial experience in working with infants).

Circulating mediators of growth and inflammation.

IGF-1, osteocalcin, IL-6, and IL-1RA were measured with high-precision ELISA using standard techniques at discharge and repeated at the end of the 1-year study period (EOS).

Neuromotor assessment.

Because the period of birth to one-year of age is developmentally dynamic, no single test can be used to assess the change in neuromotor status. We assessed the gross motor function changes that occurred over the first year of life using the TIMP at discharge from the NICU and at 3 months post discharge. AIMS was administered at 3-months post discharge and again at one year of life. This approach has been validated by a number of studies(16).

Statistical Analysis.

The original study sample size calculations were performed for a range of possible magnitude differences in body composition outcomes in the initial study protocol submitted to the NIH. According to those analyses, the required sample size to detect differences with a minimum of 80% power was determined to be 40 for effects of 1.0 and above; 70 for effect size = 0.70; 120 for effect sizes of 0.55; and 140 for effect size = 0.44.

Chi-square analyses and t-tests were performed to evaluate differences between 1) the randomized groups and 2) completers vs. non-completers on key baseline variables including sex, gestational age and birthweight. For each primary outcome (AIMS z-score, TIMP z-score, DXA measures and serum growth and inflammation factor measures) repeated measures mixed models analysis were used to evaluate the effect of intervention, time and time x intervention interaction. Main effect of sex, sex x time interactions, and sex x intervention interactions were also evaluated. The mixed models analyses satisfy intent to treat conditions in that all subjects and available data were utilized in calculation of estimated effects (regardless of completion status). Sensitivity analyses were performed restricting analyses to completers. In addition, change scores were calculated and Pearson correlations performed to determine interrelationship between the neuromotor assessments and level of change in DXA and growth and inflammation factor measures across the study period.

RESULTS

Participant Randomization and Retention (Figure 2, Consort Diagram).

A total of 163 infants were enrolled equally divided by sex and randomization to the E and C groups. 99 (61%) completed all required assessments at EOS consisting of: 24 females and 27 males in the comparison group and 22 females and 26 males in the assisted-exercise group (NS). Among the participants who did not complete the study but were willing to inform us of their discontinuation, the most common explanation was that the study burden (need to keep track of interaction with their infants and/or to perform the prescribed exercises) was too great in the context of busy family life. There were no significant differences between the assisted-exercise and comparison groups in terms of mean gestational age (E, 27 weeks; C, 27 weeks) or birthweight (E, 933 g; C, 930 g). Small for gestational age infants (SGA) comprised 9% of the E-group infants and 13% of the C-group infants (NS). In addition, participants lost to follow up did not statistically differ from those completing the 12 month visit on these baseline factors.

As expected, body weight increased over the one-year period of study. No differences were observed between the intervention and comparison groups. There were significant increases in almost all DXA measured indexes of body composition (Table 2). There was no effect of the assisted motor activity intervention on the DXA results (Figures 3 and 4). No substantial effects of SGA status on growth parameters were noted, but only 11% of the enrolled infants were SGA. Gestational age was not correlated with the degree of change in DXA or growth factor measures.

Table 2.

Major DXA findings. Baseline refers to pre-discharge DXA; Completion, at the end of study (approximately 12 months post discharge; C, active control group; and E, assisted exercise group. BMC is bone mineral content and BMD is bone mineral density. Note that each DXA measure demonstrated significant change across study duration (p < 0.005)

		Female		Male
		Baseline	Completion	Baseline	Completion
Lean (gm)	C	2761.8±89.0	6423.5±157.9	2836.0±116.1	6667.3±112.1
	E	2810.8±134.9	6277.3±127.0	2946.3±110.7	6729.1±137.1
Fat (gm)	C	506.4±72.7	2581.9±166.3	474.3±68.3	2551.8±145.4
	E	496.6±89.0	2744.2±176.0	472.7±47.8	2683.1±117.4
Mass (gm)	C	3315.8±150.7	9220.6±280.0	3359.1±169.6	9436.9±208.7
	E	3358.0±202.3	9232.5±265.7	3467.8±145.0	9644.7±232.3
BMC (g)	C	47.5±2.83	215.2±9.1	48.7±2.9	217.8±8.9
	E	50.6±5.2	211.0±7.3	48.8±2.2	232.5±5.9
BMD (g/cm2)	C	0.149±0.004	0.421±0.020	0.152±0.004	0.452±0.015
	E	0.153±0.008	0.419±0.019	0.151±0.004	0.467±0.008

Figure 3.

Change in LBM as percent of total body mass in each group. LBM as percent of total body mass decreased significantly (p < 0.001) in all subgroups. BL is baseline; EOS is end of study.

Figure 4.

Change in FM as percent of total body mass in each group. FM as percent of total body mass increased significantly (p < 0.001) in all subgroups. BL is baseline; EOS is end of study.

As shown in Table 3, there were significant changes in IGF-1, IL-1RA, and osteocalcin over the one year period of observation. IGF-I significantly increased, and both IL-1RA and osteocalcin decreased. IL-6 did not change. We found no effect of the exercise intervention. As shown in Figure 5, the change in IGF-1 was correlated to the change in LBM over the course of the study (all participants). We also found significant relationships between metrics of body fat and circulating predictive-biomarkers [n.b., we used the FDA BEST criteria (23)] related to inflammation suggesting that the greater the degree of inflammation, the smaller the accrual of body fat over the course of the study (Table 4). Finally, we found a significant inverse correlation between the change in IL-1RA and IGF-1 (r = –0.31, p = 0.0087).

Table 3.

Major circulating biomarker findings. Baseline refers to pre-discharge DXA; Completion, at the end of study (approximately 12 months post discharge; C, active control group; and E, assisted exercise group. “Osteo” refers to osteocalcin.

		Female		Male
		Baseline	Completion	Baseline	Completion
IGF-1* (ng/ml)	C	46.1±5.2	95.6±7.6	51.6±16.7	61.7±7.0
	E	56.0±6.0	73.2±8.1	52.6±6.3	70.3±7.2
IL-6 (pg/ml)	C	2.6±1.2	1.3±0.3	1.5±0.3	2.4±0.9
	E	3.8±1.8	2.4±0.9	1.8±0.6	2.1±1.0
IL-1ra* (pg/ml)	C	8200±1643	1112±107	6042±1408	1959±593
	E	5132±1148	1588±414	4275±1061	1365±150
Osteo* (ng/ml)	C	90.2±10.0	59.3±5.7	74.1±9.1	43.1±6.0
	E	96.5±12.8	52.1±3.5	90.6±13.9	55.0±5.8

significant change between baseline and completion (across condition and sex) p < 0.0125

Figure 5.

The increase in IGF-1 was correlated with the increase in LBM (r = 0.36, p = 0.0019).

Table 4.

Inverse correlations between % body fat and biomarkers of inflammation

Variables	r	p
EOS %BF vs. EOS IL1-RA	−0.23	0.0456
EOS %BF vs. EOS IL-6	−0.28	0.0149
Δ-%BF vs. EOS IL1-RA	−0.41	0.0003
Δ-%BF vs. EOS IL-6	−0.30	0.0100
Δ-IL-6 vs.EOS %BF	−0.25	0.0340
Δ-IL-6 vs. Δ-%BF	−0.25	0.0357

Neurodevelopment

We found small but unexpected changes in the TIMP and AIMS assessments of neurodevelopment (Table 5). Gestational age (birth week) was positively correlated with the TIMP scores at 3 months (r=0.3172, p=0.002) as well as the degree of TIMP change between 0–3 months (r=0.21, p=0.039). SGA status was also correlated with degree of TIMP change. Those in the SGA group exhibited larger decrease in TIMP z-score across the 3 months compared to the non SGA group (mean change SGA was −1.15; mean change non SGA was −0.522, p=0.034). No additional effect of SGA status on TIMP or AIMS was observed.

Table 5.

TIMP and AIMS Z-scores. TIMP was performed at baseline and at 3 months. AIMS was performed at 3 months and end of study (EOS).

		Female		Male
TIMP*		Baseline	3 months	Baseline	3 months
	C	0.116±0.146	–0.247±0.121	0.208±0.131	–0.357±0.149
	E	0.232±0.111	–0.422±0.178	0.187±0.168	–0.690±0.147
AIMS		3 months	EOS	3 months	EOS
	C	0.101±0.290	–0.007±0.218	–0.302±0.229	–0.354±0.162
	E	0.280±0.258	–0.575±0.180	0.120±0.192	–0.476±0.219

Significant reduction in TIMP z-score decrease between baseline and 3 months (p < 0.0001)

Relationship between body composition and neurodevelopment

We found significant correlations between the AIMS assessment of neuromotor function and LBM determined by DXA over the course of the study (Table 6 and Figure 6).

Table 6.

Correlations between LBM and AIMS

	Female		Male		Overall
	R	P	R	P	R	P
AIMS change	0.37632	0.0283	0.17446	0.2816	0.28267	0.0147
AIMS EOS	0.43521	0.0071	0.36554	0.0098	0.38225	0.0003

Figure 6.

The increase in LBM was correlated with the AIMS z-score at EOS (r = 0.31, p < 0.001)

Sex differences

As shown in Table 7, we found a number of sexual dimorphisms over the course of the study.

Table 7.

Summary of significant sex differences in DXA, circulating biomarkers, and neuromotor assessment

DXA	LBM: Females lower at EOS, p = 0.0025BMD: Females lower at EOS, p = 0.0123
Circulating biomarkers	IGF-1: Females higher at EOS, p = 0.027

DISCUSSION

Gauging the effect of physical and motor activity on the development of body composition in premature infants is challenging due to factors such as achieving an adequate study sample size, distinguishing specific effects of motor activity on body composition when rapid changes in growth and growth mediators are occurring naturally, and the limited methodologies capable of precise measurements of muscle, fat, and bone. The longitudinal data that we observed over a roughly one-year period in a cohort of prematurely born infants provide novel insights into the patterns of body composition growth in this at-risk population. Sexual dimorphisms were observed in key metrics, thus, sex must be accounted for in studies of growth and development from very early in life. We did not demonstrate that our specific caregiver implemented exercise intervention altered the trajectory of growth and development, perhaps because we underestimated the degree of training and support necessary for a caregiver administered program to succeed. Nonetheless, we speculate that the association between LBM and neuromotor assessment over the study duration suggests that levels of physical and motor activity may play a role in the broader development of body composition.

An intriguing observation from the study was that neuromotor assessment at the end of the study was significantly correlated with DXA measures of LBM (Table 6, Figure 6), in support of a key study hypothesis. The TIMP and AIMS rely on the baby’s motor response to various external stimuli and scale functional capacities and the quality of movement. Muscle function and size, in turn, depend in large measure on the repetitive use of the nerves and muscles involved in physical activity. This is the basis of the training effect known to occur later in life, but the connection between muscle utilization and muscle size and function can be observed early in life as well. Brachial plexus injury at birth leads to reduced muscle mass in the first year of life (24). Our earlier study in postnatal rats cited above showed that increasing motor activity in the immediate postnatal period could lead to increased muscle mass later in life (7). We speculate that higher levels of motor activity in some infants (for whatever reasons, environmental or innate behavior) were ultimately reflected in both better standardized tests of neuromotor function and increased LBM.

An additional major goal of the study was to determine whether growth and neuromotor trajectories in prematurely born infants could be influenced by a caregiver implemented intervention designed to increase physical and motor activity. The intervention appeared to have no effect on DXA measures of body composition or on neuromotor function. A few previous studies conducted before discharge from the NICU have shown that a variety of interventions involving assisted exercise (recently reviewed by Eliakim et al (25)) and massage (recently reviewed by Alvarez et al (26)) may positively influence growth indexes and hospital stay. These previous studies were short term in duration and the intervention was conducted by trained personnel in the NICU.

In contrast, our study attempted to train caregivers/parents to provide assisted exercise in the participants’ homes. A major limitation of this approach was the difficulty in quantifying the exercise “dose,” the actual amount of interaction time between the caregiver and the baby and amount of increased physical and motor activity and performance that resulted from the interaction. While we did visit the participants’ home every three months to teach the parents developmentally appropriate exercises, and attempted to contact the care providers up to three times on the months that they were not visited, we recognize that these are not optimal metrics of dose fidelity. Studies designed to improved neuromotor development in premature infants in the post NICU discharge period have been successful, but have also demonstrated that the beneficial effects of regular neuromotor and physical activity can disappear upon cessation of active intervention and supervision by trained professionals (27). It is possible that we underestimated the amount of training and support needed by often-busy and stressed caregivers(28) to consistently administer a motor-activity program capable of altering neurodevelopment and/or body composition. This burden may have contributed to the 39% dropout rate we observed over the course of the year-long observation period.

There was a small but significant reduction in the TIMP z-score between baseline and 3-months. The AIMS z-scores were lower at 3-months and remained lower at EOS (Table 5). Emerging data in premature infants suggests that sustained improvement in neuromotor function depends on continuous, regular intervention by caregivers or providers (19). One possible explanation for our data is that despite our efforts, the level of direct intervention to enhance neuromotor function in premature infants in our region remains suboptimal. Although the SGA infants demonstrated reduced TIMP over the first 3 months after discharge, we observed no further effect of SGA on the AIMS at EOS.

We gained insight into some possible biological mechanisms that play a role in the control of body composition early in life in prematurely born infants. IGF-1 increased substantially in our cohort and there was a positive correlation between the increase in IGF-1 and the increase in LBM over the study duration (Figure 5). Circulating levels of IGF-1 and its related binding proteins are associated with muscle mass, exercise training, and disuse across the lifespan(29,30). An inverse correlation between IGF-1 and circulating indicators of inflammation have been observed early in postnatal life in prematurity (9,11). In the present study we noted increases in IGF-1 and decreases in IL-1ra (as well as a significant inverse correlation) suggesting that the inverse relationship between growth factors and inflammation can be observed during the first year of postnatal life in infants born prematurely.

In recent years, the observation of increased rates of obesity later in life in infants born prematurely (whether SGA or appropriate-weight for gestational age) has formed the hypothesis that abnormal “catch-up fat” accumulation in early postnatal life may play a role (31). A novel observation from our study was the inverse correlation between body fat accumulation and circulating indicators of inflammation (Table 4). Murine models show that IL-6 inhibits growth in postnatal life (32). In adults, circulating IL-6 is associated with sarcopenia and cachexia(33), and IL-6 stimulates lipolysis in adipocytes(34), indicating, possibly, a direct inhibitory effect of inflammatory mediators on fat tissue accumulation in postnatal life. Our data suggest that the balance between growth factors and antagonistic proinflammatory mediators influence fat and lean tissue accumulation early in life in prematurely born infants.

We found a significant decrease in osteocalcin over the study period. This was observed despite the increase in BMD and BMC. Osteocalcin is higher in children compared to adults, peaking in both boys and girls at the age of the pubertal growth spurt (35,36). The decline in osteocalcin suggests that serum levels may reflect growth velocity rather than growth in absolute terms. Data from premature infants reveals that linear growth velocity is as high as 1.4–1.6 cm/week at 30–34 weeks post gestational age and declines to about 0.7 cm/week at 50 weeks post gestational (37,38). Most likely, bone growth and mineralization continued over the duration of the study, but the declining rate of bone growth was reflected by the declining osteocalcin levels.

Little is known regarding sexual dimorphism in growth and development in the first year of postnatal life in infants born prematurely. We found evidence for sex effects in body composition and growth mediators. BMD was lower at EOS in the females. Reduced peak bone mass has been observed in the 3rd decade of life of individuals with a history of premature birth and low birth-weight, but no sex differences were observed (39). We also found greater lean body mass at EOS in the male infants. Fields et al. (40) noted greater lean tissue in full term male compared with female infants at 1 month of age, estimated using whole body plethysmography. In the Fields’ study, sex differences disappeared by 6 months of age, leading the authors to conjecture that the lean mass differences paralleled the higher levels of androgen levels at birth in male infants which dissipates roughly by 6 months. Despite the lower LBM levels in the females at EOS, their IGF-1 circulating levels were higher.

Conclusion

This study reports potentially useful information about changes in body composition and associated circulating growth biomarkers over the first year of life following NICU discharge in infants born prematurely. Our attempts to increase muscle mass and neuromotor development through a parent provided assisted exercise intervention was, however, not successful. We found a significant association between indexes of neuromotor development and body composition, but whether increased neuromotor development and/or motor activity stimulated LBM growth, or visa versa could not be determined from our data. These observations form the basis for studies that can optimize the enhanced physical activity “dose” over the long term and provides insights/considerations for how to support parent compliance for busy caregivers and families of prematurely born infants.